Loading…

No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty

Abstract Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significa...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of arthroplasty 2014-11, Vol.29 (11), p.2109-2112
Main Authors: Maheshwari, Aditya V., MD, Korshunov, Yevgeiny, MD, Naziri, Qais, MD, Pivec, Robert, MD, Mont, Michael A., MD, Rasquinha, Vijay J., MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3
cites cdi_FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3
container_end_page 2112
container_issue 11
container_start_page 2109
container_title The Journal of arthroplasty
container_volume 29
creator Maheshwari, Aditya V., MD
Korshunov, Yevgeiny, MD
Naziri, Qais, MD
Pivec, Robert, MD
Mont, Michael A., MD
Rasquinha, Vijay J., MD
description Abstract Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significant difference in the hemoglobin levels (all 9.5–10 g/dL) on each of three postoperative days. There was also no significant difference in the intraoperative blood loss, postoperative blood loss or the total perioperative blood loss in both groups. The mean requirement in each patient was 2.5 ± 2.4 units in the fibrin sealant group compared to 2.0 ± 0.8 units in the non-fibrin sealant group. We have stopped using fibrin sealant based on this study.
doi_str_mv 10.1016/j.arth.2014.02.034
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629966074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S088354031400148X</els_id><sourcerecordid>1629966074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3</originalsourceid><addsrcrecordid>eNp9UU1P3DAUtCqqsqX9Az1UPnJJ8FecrFQhLVBK1VVBAgQ3y7FfipdsvLUdpD3x1-toaQ89oHew9DwzejOD0CdKSkqoPFqVOqSHkhEqSsJKwsUbNKMVZ0UjiNxDM9I0vKgE4fvofYwrQiitKvEO7TPRUC5FPUPPPz1eWOuS84Pu8QkM0LmE71x6wLcRsO-wxueuDW7A16B7PSScPD4DE0Dn_ysIrrjcQNDJPQE-6b23eOljxGdj5vzCV8GtddjiG5-y_o8BAC_y1cFveh3T9gN62-k-wseX9wDdnn-9Ob0olpffvp8uloXJp6ZCS17XvJacdzVQYNp2gouaWaJbySmVhrWsaltitbE0T0uN1O3c5BUhoPkBOtzpboL_PUJMau2igT4bAj9GRSWbz6UktchQtoOakH0E6NRm50FRoqbg1UpNwaspeEWYysFn0ucX_bFdg_1H-Zt0BnzZASC7fHIQVDQOBgPWBTBJWe9e1z_-j256Nzij-0fYQlz5MeT-sg8VM0FdT9VPzVORWxfNPf8DdYWqIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629966074</pqid></control><display><type>article</type><title>No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty</title><source>ScienceDirect Freedom Collection</source><creator>Maheshwari, Aditya V., MD ; Korshunov, Yevgeiny, MD ; Naziri, Qais, MD ; Pivec, Robert, MD ; Mont, Michael A., MD ; Rasquinha, Vijay J., MD</creator><creatorcontrib>Maheshwari, Aditya V., MD ; Korshunov, Yevgeiny, MD ; Naziri, Qais, MD ; Pivec, Robert, MD ; Mont, Michael A., MD ; Rasquinha, Vijay J., MD</creatorcontrib><description>Abstract Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significant difference in the hemoglobin levels (all 9.5–10 g/dL) on each of three postoperative days. There was also no significant difference in the intraoperative blood loss, postoperative blood loss or the total perioperative blood loss in both groups. The mean requirement in each patient was 2.5 ± 2.4 units in the fibrin sealant group compared to 2.0 ± 0.8 units in the non-fibrin sealant group. We have stopped using fibrin sealant based on this study.</description><identifier>ISSN: 0883-5403</identifier><identifier>EISSN: 1532-8406</identifier><identifier>DOI: 10.1016/j.arth.2014.02.034</identifier><identifier>PMID: 24813647</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Arthroplasty, Replacement, Knee ; Blood Loss, Surgical - prevention &amp; control ; Blood Transfusion ; Female ; fibrin sealant ; Fibrin Tissue Adhesive - therapeutic use ; Hematocrit ; Hemoglobins - analysis ; hemostasis ; Hemostatics - therapeutic use ; Humans ; Length of Stay ; Male ; Middle Aged ; Orthopedics ; Postoperative Hemorrhage - prevention &amp; control ; Retrospective Studies ; total knee</subject><ispartof>The Journal of arthroplasty, 2014-11, Vol.29 (11), p.2109-2112</ispartof><rights>Elsevier Inc.</rights><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3</citedby><cites>FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24813647$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maheshwari, Aditya V., MD</creatorcontrib><creatorcontrib>Korshunov, Yevgeiny, MD</creatorcontrib><creatorcontrib>Naziri, Qais, MD</creatorcontrib><creatorcontrib>Pivec, Robert, MD</creatorcontrib><creatorcontrib>Mont, Michael A., MD</creatorcontrib><creatorcontrib>Rasquinha, Vijay J., MD</creatorcontrib><title>No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty</title><title>The Journal of arthroplasty</title><addtitle>J Arthroplasty</addtitle><description>Abstract Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significant difference in the hemoglobin levels (all 9.5–10 g/dL) on each of three postoperative days. There was also no significant difference in the intraoperative blood loss, postoperative blood loss or the total perioperative blood loss in both groups. The mean requirement in each patient was 2.5 ± 2.4 units in the fibrin sealant group compared to 2.0 ± 0.8 units in the non-fibrin sealant group. We have stopped using fibrin sealant based on this study.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arthroplasty, Replacement, Knee</subject><subject>Blood Loss, Surgical - prevention &amp; control</subject><subject>Blood Transfusion</subject><subject>Female</subject><subject>fibrin sealant</subject><subject>Fibrin Tissue Adhesive - therapeutic use</subject><subject>Hematocrit</subject><subject>Hemoglobins - analysis</subject><subject>hemostasis</subject><subject>Hemostatics - therapeutic use</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Orthopedics</subject><subject>Postoperative Hemorrhage - prevention &amp; control</subject><subject>Retrospective Studies</subject><subject>total knee</subject><issn>0883-5403</issn><issn>1532-8406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9UU1P3DAUtCqqsqX9Az1UPnJJ8FecrFQhLVBK1VVBAgQ3y7FfipdsvLUdpD3x1-toaQ89oHew9DwzejOD0CdKSkqoPFqVOqSHkhEqSsJKwsUbNKMVZ0UjiNxDM9I0vKgE4fvofYwrQiitKvEO7TPRUC5FPUPPPz1eWOuS84Pu8QkM0LmE71x6wLcRsO-wxueuDW7A16B7PSScPD4DE0Dn_ysIrrjcQNDJPQE-6b23eOljxGdj5vzCV8GtddjiG5-y_o8BAC_y1cFveh3T9gN62-k-wseX9wDdnn-9Ob0olpffvp8uloXJp6ZCS17XvJacdzVQYNp2gouaWaJbySmVhrWsaltitbE0T0uN1O3c5BUhoPkBOtzpboL_PUJMau2igT4bAj9GRSWbz6UktchQtoOakH0E6NRm50FRoqbg1UpNwaspeEWYysFn0ucX_bFdg_1H-Zt0BnzZASC7fHIQVDQOBgPWBTBJWe9e1z_-j256Nzij-0fYQlz5MeT-sg8VM0FdT9VPzVORWxfNPf8DdYWqIQ</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Maheshwari, Aditya V., MD</creator><creator>Korshunov, Yevgeiny, MD</creator><creator>Naziri, Qais, MD</creator><creator>Pivec, Robert, MD</creator><creator>Mont, Michael A., MD</creator><creator>Rasquinha, Vijay J., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty</title><author>Maheshwari, Aditya V., MD ; Korshunov, Yevgeiny, MD ; Naziri, Qais, MD ; Pivec, Robert, MD ; Mont, Michael A., MD ; Rasquinha, Vijay J., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arthroplasty, Replacement, Knee</topic><topic>Blood Loss, Surgical - prevention &amp; control</topic><topic>Blood Transfusion</topic><topic>Female</topic><topic>fibrin sealant</topic><topic>Fibrin Tissue Adhesive - therapeutic use</topic><topic>Hematocrit</topic><topic>Hemoglobins - analysis</topic><topic>hemostasis</topic><topic>Hemostatics - therapeutic use</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Orthopedics</topic><topic>Postoperative Hemorrhage - prevention &amp; control</topic><topic>Retrospective Studies</topic><topic>total knee</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maheshwari, Aditya V., MD</creatorcontrib><creatorcontrib>Korshunov, Yevgeiny, MD</creatorcontrib><creatorcontrib>Naziri, Qais, MD</creatorcontrib><creatorcontrib>Pivec, Robert, MD</creatorcontrib><creatorcontrib>Mont, Michael A., MD</creatorcontrib><creatorcontrib>Rasquinha, Vijay J., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of arthroplasty</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maheshwari, Aditya V., MD</au><au>Korshunov, Yevgeiny, MD</au><au>Naziri, Qais, MD</au><au>Pivec, Robert, MD</au><au>Mont, Michael A., MD</au><au>Rasquinha, Vijay J., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty</atitle><jtitle>The Journal of arthroplasty</jtitle><addtitle>J Arthroplasty</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>29</volume><issue>11</issue><spage>2109</spage><epage>2112</epage><pages>2109-2112</pages><issn>0883-5403</issn><eissn>1532-8406</eissn><abstract>Abstract Blood loss remains a substantial problem associated TKA. This study evaluated the efficacy of a fibrin sealant on: (1) blood loss; (2) blood transfusions; and (3) length of stay. We evaluated the records of 113 consecutive patients with sealant and 70 without sealant. There was no significant difference in the hemoglobin levels (all 9.5–10 g/dL) on each of three postoperative days. There was also no significant difference in the intraoperative blood loss, postoperative blood loss or the total perioperative blood loss in both groups. The mean requirement in each patient was 2.5 ± 2.4 units in the fibrin sealant group compared to 2.0 ± 0.8 units in the non-fibrin sealant group. We have stopped using fibrin sealant based on this study.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24813647</pmid><doi>10.1016/j.arth.2014.02.034</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0883-5403
ispartof The Journal of arthroplasty, 2014-11, Vol.29 (11), p.2109-2112
issn 0883-5403
1532-8406
language eng
recordid cdi_proquest_miscellaneous_1629966074
source ScienceDirect Freedom Collection
subjects Adult
Aged
Aged, 80 and over
Arthroplasty, Replacement, Knee
Blood Loss, Surgical - prevention & control
Blood Transfusion
Female
fibrin sealant
Fibrin Tissue Adhesive - therapeutic use
Hematocrit
Hemoglobins - analysis
hemostasis
Hemostatics - therapeutic use
Humans
Length of Stay
Male
Middle Aged
Orthopedics
Postoperative Hemorrhage - prevention & control
Retrospective Studies
total knee
title No Additional Benefit With Use of a Fibrin Sealant to Decrease Peri-Operative Blood Loss During Primary Total Knee Arthroplasty
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T16%3A15%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=No%20Additional%20Benefit%20With%20Use%20of%20a%20Fibrin%20Sealant%20to%20Decrease%20Peri-Operative%20Blood%20Loss%20During%20Primary%20Total%20Knee%20Arthroplasty&rft.jtitle=The%20Journal%20of%20arthroplasty&rft.au=Maheshwari,%20Aditya%20V.,%20MD&rft.date=2014-11-01&rft.volume=29&rft.issue=11&rft.spage=2109&rft.epage=2112&rft.pages=2109-2112&rft.issn=0883-5403&rft.eissn=1532-8406&rft_id=info:doi/10.1016/j.arth.2014.02.034&rft_dat=%3Cproquest_cross%3E1629966074%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-a637737633f7e1e2adf43472d0ab63116c2b25bb0dacd1d1db1c6ab9cbb000ea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1629966074&rft_id=info:pmid/24813647&rfr_iscdi=true